OncoImmunology · 2015 · 45 citations · 44 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyMolecular OncologyB Cell BiologyCancer ImmunotherapyLymphoid NeoplasmsNatural Killer Cell BiologyNatural Killer Cell FunctionNatural Killer Cell RegulationB-cell Immune EscapeGerminal Center BiologyImmune Escape AvoidanceLymphoma PathogenesisNatural Killer Cell Effector FunctionsNatural Killer Cell SuppressionNatural Killer Cell-based Cancer ImmunotherapyNatural Killer-cell Lymphoma
Non-Hodgkin's lymphomas (NHLs) are malignant neoplasms which are clinically and biologically diverse. Their incidence is constantly increasing and despite treatment advances, there is a need for novel targeted therapies. Here, we identified Lectin-like transcript 1 (LLT1) as a biomarker of germinal center (GC)-derived B-cell NHLs. LLT1 identifies GC B cells in reactive tonsils and lymph nodes and its expression is maintained in B-cell NHLs which derive from GC, including Burkitt lymphoma (BL), follicular lymphoma (FL), and GC-derived diffuse large B-cell lymphoma (DLBCL). We further show that LLT1 expression by tumors dampens natural killer (NK) cell functions following interaction with its receptor CD161, uncovering a potential immune escape mechanism. Our results pinpoint LLT1 as a novel biomarker of GC-derived B-cell NHLs and as a candidate target for innovative immunotherapies.
44
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Ash A. Alizadeh, Michael B. Eisen, R. Eric Davis et al. · Nature · 2000 · 10K citations
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Federica Sallusto, Danielle Lenig, Reinhold Förster et al. · Nature · 1999 · 5.8K citations